Call for Abstract

11th International Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, will be organized around the theme “”

PERSONALIZED MEDICINE 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in PERSONALIZED MEDICINE 2023

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

A biomarker and sub-atomic markers are the quantitative indicators of the severity or proximity of an infectious condition in medicine. A  molecularbiomarker is, more generally speaking, anything that can be used to identify a particular disease state or another physiological condition in a living entity. The centre has transitioned from predictions using the traditional anatomical arranging frameworks to direct the decision of treatment for an individual patient to a coordinated methodology using the hereditary cosmetics of the  braintumour and the genotype of the patient in the current era of stratified solution and biomarker-driven treatments. The enhancement of biomarkers like has been greatly aided by genomics and other technological advancements.


Contrasts between species are what determine a customised solution. It is a truism that little differences in a person's genetic makeup can generate emotional contrasts due to illnesses or advanced medications, as well as the effects of personalised pharmaceuticals on society. In any given complicated framework, minor adjustments to the starting circumstances can have a radically different impact on the outcomes. Despite interspecies variation and human variation within species, nonhuman species continue to be the primary source of knowledge for individualised solutions that improve human wellbeing.


The most significant factors in daily life are our lifestyle and behaviour, both of which have  an impact on our health. The goal of lifestyle medicine is to change and encourage the patient's habits and behaviour. Additionally, it promotes healthy eating habits, frequent exercise, stress reduction, and pleasant social interaction. The method of treating and eliminating infection is with life drugs. Life medicine is now the preferred approach and can most effectively treat diseases like:


A growing field of medicine known as "personalised medicine" makes decisions about the prevention, disease diagnosis, and treatment of illness based on a patient's hereditary profile. The genetic profile of a patient can help medical professionals choose the optimal medication or treatment and administer it using the appropriate measurement or regimen. As a therapy method and personalised growth solution, Diabetes-related illness risk assessment and management, pharmaceutics personalised: new techniques and financial implications, Applications of be spoke medication in rare diseases

All doctors do preventive medicine to keep their patients healthy. Additionally, the American Board of Medical Specialties regards it as an exceptional medical claim to fame (ABMS). The focus of preventive medicine is on the health of individuals, communities, and specific populations. Additionally, it is used to treat stoutness and vision impairment. The Epidemiology Division uses research techniques to understand the manifestations and causes of health illness in the general population and to translate this understanding into projects meant to prevent disease. The division has a long history of participating in NIH-funded multi-site, longitudinal partner studies, and their staffs oversees a large number of professionally initiated, NIH-funded research projects and trials. Its staff oversees various expert-started, NIH-supported research projects and trials. NIH-supported multi-site, longitudinal partner studies


Clinical immunology is the study of illnesses brought on by immune system abnormalities. It also includes illnesses affecting other systems, where immune responses influence the pathophysiology and clinical characteristics. Numerous immune system elements are truly cellular in origin and are not connected to any one organ but rather are embedded or moving through different tissues all over the body. A novel type of cancer therapy called immunotherapy uses the immune system's natural ability to combat cancer. These medicines may have higher potential than current therapy methods to fight cancer more effectively, to provide longer-term protection against the disease, to have fewer side effects, and to benefit more people due to the immune system special abilities

According to scientists, Alzheimer's disease affects the majority of people as a result of a confluence of hereditary, environmental, and lifestyle variables that have an ongoing negative impact on the brain. Dopamine-producing cells begin to die in Parkinson's disease. Dopamine is a substance that aids in regular movement. Parkinson's disease has no recognised causal aetiology. One notion holds that it might run in the family. According to other views, living in rural areas and being exposed to pesticides may be the root causes.



A growing field of medicine known as "personalised medicine" makes decisions about      the  prevention, diagnosis, and treatment of illness based on a patient's hereditary  diseases profile. The   genetic profile of a patient can help medical professionals choose the optimal medication or treatment and administer it using the appropriate measurement or regimen. As a therapy method and personalised growth solution, Diabetes-related illness: risk assessment and management, pharmaceutical personalised: new techniques and financial implications, Applications of bespoke medication in rare diseases, Implications of tailored prescription in HIV treatment Health Translation.

The prevention, diagnosis, and treatment of sickness are determined based on a patient's hereditary profile in the expanding discipline of "personalised medicine." Medical personnel can select the best drug therapy for a patient and deliver it using the right measurement or regimen with the help of the patient's genetic profile. Diabetes-related illness: risk assessment and treatment, pharmacologicaltreatment        personalization: new methodologies and consequences for the economy, applications of customised medicine for rare disorders, Effects of customised medication in HIV therapy Health Translation.


P4 Medicine is a plan to use biotechnology to significantly improve the nature of human       life. Predictive, preventive, personalised, and molecularmedicine are also referred to as P4 Medicine, a concept coined by academic Leroy Hood. P4 Medicine was created because, over the next 20 years, biotechnology will change restorative medicine to focus on a patient's wellbeing rather than an infection. The medical specialty overseeing the prevention, diagnosis, and treatment of adult diseases is known as internal solution or general medication (in Commonwealth nations). One of medicine's claims to fame is the care of adult and paediatric patients who have severe illnesses or wounds that require prompt medical attention.


The goal of personalised medicine is to either keep an illness at bay or completely reduce its impact on the patient. It entails predicting the possibility of disease and putting preventive measures in place (for example, by avoiding mortality or constraining dreariness).Newbornscreening, diagnostictesting, medical bioinformatics, prenatal testing, carrier testing, and preconception testing are all methods and measures. A general health initiative called "infant screening" is designed to check infants soon after conception for a number of disorders that are curable but not yet clinically apparent. Testing conducted prior to conception is known as prenatal testing and is used to look for diseases and disorders in a hatchling or developing life.


   The manipulation of matter on a nuclear, atomic, and supramolecular scale is referred to as nanotechnology (or "nanotech"). The earliest, most widespread depiction of nanotechnology made reference to the specific mechanical goal of precisely manipulating particles and atoms for the development of large size objects, which is also now made reference to as sub-atomic nanotechnology. Pharmaceutical applications of nanotechnology and cell-based therapy Nanotechnology and biotechnology use molecular systems as their tools and strategies.


The term "psychotherapy" refers to talking with a psychiatrist regarding mental health problems. During psychotherapy, we gain knowledge about our current circumstances, feelings, moods, thoughts, and behaviour. The two most popular types of psychotherapy are cognitive behavioural therapy and psychodynamic therapy. The following are the top five types of psychotherapy:


The ethics of personalized medicine became a matter when some laboratory tests resulted in women incorrectly she has been told that they have a high risk of breast or ovarian cancer. Ethical issues are not confined to the utilization of genetic information but can be raised with the possession of human material for the advancement of knowledge. Personalized medicine is that branch of medicine whereby a patient’s treatment and forecast are based on his genes. Recent genetic research explains the variations and similarities between humans and their diseases, and universities have not set stringent, some numerous tests and kits are valid for some suspect biomarkers.


Based on a person's genes, genetic illnesses are treated, primarily by correcting hereditary metabolic disorders Typically, a biochemical genetics specialist and a primary care physician co-manage this. Additional illnesses are treatable as the biology of other hereditary abnormalities has been better understood. In some circumstances, primary care physicians are likely to employ new medicines for multifactorial disorders if genetic testing uncover them. The fundamentals of treating the disorder itself are an essential component of genetic and genomic (medical genomics) understanding.



Medicine and public health, recognizing the inherent interdependency of these fields, established the Medicine/Public Health Initiative in the mid and evolving forum in which representatives of both sectors can explore their mutual interests in improving health and define collaborative mechanisms to achieve that goal. The creativity participants developed six goals that they and others in medicine and public health across the nation should implement: engage the community; community Health  change the education process; create joint research attempts by clinical, public health, and preventive medicine investigators, develop a shared view of illness between medicine and public health, working together to provide health care and work jointly to develop health care assessment measures. The authors describe the six goals in-depth and explain the important combined roles of clinically-oriented preventive medicine and community-oriented preventive medicine as practiced in a model of health care delivery called community-oriented primary care in implementing the Initiative's goals. They then report recent efforts, including two in Boston and Dallas, to merge medicine and public health, and state that academic health cancer’s, which are in the process of reshaping themselves, can help themselves as well as the public by holding their key role in the effort to integrate medicine and public health. In particular, they can expand and strengthen existing training programs in preventive medicine and COPC or add these programs to their modules.


Personalized medicine is a materializing practice of medicine that uses an individual’s genetic profile to guide decisions made regarding prevention, diagnosis, and treatment of disease genetic makeup, it is beginning to control the limitations of traditional medicine. Personalized medicine is the changing of medical treatment to the separate characteristics of each patient. Personalized medicine can be considered in addition to the traditional process of understanding and treating disease. Physicians can select a treatment protocol based on the patient’s molecular profile. Personalized medicine has possible to change the way of thinking about healthcare, then identify those and manage health problems.


When women were given inaccurate information about their risk of breast or ovarian cancer as a result of some laboratory tests, the ethics of personalised care came into question. Ethics concerns can also be raised with the holding of human material for scientific research, not just with using genetic information. The area of medicine known as personalised medicine bases a patient's treatment and prognosis on his genes. Universities have not set strict guidelines, therefore a variety of tests and kits are valid for some questionable biomarkers. Recent genetic research reveals the differences and similarities between people and their disorders.


Stem cell treatments, also known as regenerative medicine, promote the repair response of diseased, defective, or injured tissue using stem cells or their derivatives. In organ transplant and uses cells instead of donor organs, which are limited in supply? A stem cell line is a group of cells that all plunge from a single original stem cell and are grown in a lab. Cells in a stem cell line keep growing but don't differentiate into specialized cells. Generally, they remain free of genetic defects and continue to create more stem cells. Groups of cells can be taken from a stem cell line and preserved for storage or shared with other researchers. Some researchers have already shown that adult bone marrow cells guided to become heart-like cells can repair heart tissue in people, and more research is continuing. The cells of a stem cell line continue to proliferate without dividing into other cell types.


The study of metabolites produced by the body and their quantification and analysis is known as metabolomics. Pharmacometabolomics is a branch of this discipline. It describes the precise measurement of metabolites in a person's physiological fluids, imagines or assesses how pharmaceutical chemicals are metabolised, and enhances comprehension of the pharmacokinetic profile of a medicine. Contrarily, pharmacometabolomics can be used to assess metabolite levels after a pharmacological substance has been administered in order to track the compound's effects on specific metabolic pathways. This gives a thorough picture of how drugs affect metabolism and the pathways that may play a role in the variability of treatment response. Additionally, the metabolic profile of a person at baseline reveals variation within a population health  and offers information about how people respond to treatment